Anti-programmed cell death-1 (PD-1) monoclonal antibodies involve reversible cranial dura matter

This case is the first document to describe a patient receiving anti-programmed cell death 1 (PD-1) antibodies which showed cranial dura matter involvement. According to the increasing use of anti-PD-1 monoclonal antibodies, adverse effects can occur in several organs since its ligand PD-L1 and PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataoka, Hiroshi, Shimada, Daisuke, Nanaura, Hitoki, Sugie, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436277/
https://www.ncbi.nlm.nih.gov/pubmed/34527250
http://dx.doi.org/10.1093/omcr/omab077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436277/
https://www.ncbi.nlm.nih.gov/pubmed/34527250
http://dx.doi.org/10.1093/omcr/omab077

Ejemplares similares